Список литературы

Поставить закладку

Kasiske BL, Cangro CB, Hariharan S, et al. The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant. 2001; 1 Suppl 2: 3–95.
Argente-Pla M, Pérez-Lázaro A, Martinez-Millana A, et al. Simultaneous Pancreas Kidney Transplantation Improves Cardiovascular Autonomic Neuropathy with Improved Valsalva Ratio as the Most Precocious Test. J Diabetes Res. 2020; 7574628. doi: 10.1155/2020/7574628.
St Michel D, Donnelly T, Jackson T, et al. Assessing Pancreas Transplant Candidate Cardiac Disease: Preoperative Protocol Development at a Rapidly Growing Transplant Program. Methods Protoc. 2019; 2(4): 82. doi: 10.3390/mps2040082.
Chadban SJ, Staplin ND. Is it time to increase access to transplantation for those with diabetic end-stage kidney disease? Kidney Int. 2014; 86: 464–466.
Van Loo, A.A., et al. Pretransplantation hemodialysis strategy influences early renal graft function. J Am Soc Nephrol. 1998; 9: 473.
Kandaswamy R, Stock PG., Gustafson SK et al. OPTN/SRTR 2016 Annual Data Report: Pancreas. Am. J. Transplant. 2018; 18: 114–171. doi: 10.1111/ajt.14558. PMID: 29292605.
Мартынов СА, Северина АС, Ларина ИИ, и др. Подготовка пациента с сахарным диабетом 1 типа на заместительной почечной терапии диализом к трансплантации почки. Проблемы Эндокринологии. 2020; 66(6): 18-30. https://doi.org/10.14341/probl12686.
Regmi S, Rattanavich R, Villicana R. Kidney and pancreas transplant candidacy. Current Opinion in Organ Transplantation: 2021; 26 (1): 62-68. doi: 10.1097/MOT.0000000000000843.
Parajuli S, Swanson KJ, Patel R, et al. Outcomes of simultaneous pancreas and kidney transplants based on preemptive transplant compared to those who were on dialysis before transplant - a retrospective study. Transpl Int. 2020. doi: 10.1111/tri.13665. Online ahead of print.
Thomsen T, Villebro N, Moller AM. Interventions for preoperative smoking cessation. Cochrane Database Syst Rev. 2014: CD002294.
Duerinckx N, Burkhalter H, Engberg SJ, et al. Correlates and Outcomes of Posttransplant Smoking in Solid Organ Transplant Recipients: A Systematic Literature Review and Meta-Analysis. Transplantation. 2016; 100: 2252–2263.
Nourbala MH, Nemati E, Rostami Z, et al. Impact of cigarette smoking on kidney transplant recipients: a systematic review. Iran J Kidney Dis. 2011; 5: 141–148.
Corbett C, Armstrong MJ, Neuberger J. Tobacco smoking and solid organ transplantation. Transplantation. 2012; 94: 979–987. doi: 10.1097/TP.0b013e318263ad5b.
, Larry A. Weinrauch, John A. D"Elia. Effects of Smoking on Solid Organ Transplantation Outcomes. The American Journal of Medicine. 2019; 132 (4): 413-419. https://doi.org/10.1016/j.amjmed.2018.11.005.
Sampaio MS, Reddy PN, Kuo HT, et al. Obesity was associated with inferior outcomes in simultaneous pancreas kidney transplant. Transplantation. 2010; 89(9): 1117-25. doi: 10.1097/TP.0b013e3181d2bfb2. PMID: 20164819.
Molnar MZ, Streja E, Kovesdy CP, et al. Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients. Am J Transplant. 2011; 11: 725–736.
Troppmann C, Santhanakrishnan C, Kuo JH, et al. Impact of panniculectomy on transplant candidacy of obese patients with chronic kidney disease declined for kidney transplantation because of a high-risk abdominal panniculus: A pilot study. Surgery. 2016; 159: 1612–1622.
Domingueti CP, Dusse LM, Carvalho Md, et al. Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. Diabetes Complications. 2016; 30(4): 738-45. doi: 10.1016/j.jdiacomp.2015.12.018.
Zimmerman D, Sood MM, Rigatto C, et al. Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis. Nephrol Dial Transplant. 2012; 27: 3816–3822.
Garg L, Chen C, Haines DE. Atrial fibrillation and chronic kidney disease requiring hemodialysis - Does warfarin therapy improve the risks of this lethal combination? Int J Cardiol. 2016; 222.
Olbrisch ME, Benedict SM, Ashe K, et al. Psychological assessment and care of organ transplant patients. J Consult Clin Psychol. 2002; 70: 771–783.
Dew MA, Switzer GE, DiMartini AF, et al. Psychosocial assessments and outcomes in organ transplantation. Prog Transplant. 2000; 10: 239–259.
Maldonado JR et al. The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT): a new tool for the psychosocial evaluation of pre-transplant candidates. Psychosomatics. – 2012; 53 (2): 123-132.
Natori Y, Albahrani S, Alabdulla M, et al. Risk factors for surgical site infection after kidney and pancreas transplantation. Infect Control Hosp Epidemiol. 2018; 39(9): 1042-1048. doi: 10.1017/ice.2018.148.
Broggi E, Bruyere F, Gaudez F, et al. Risk factors of severe incisional hernia after renal transplantation: a retrospective multicentric casecontrol study on 225 patients. World J Urol. 2017; 35: 1111–1117.
Ooms LS, Verhelst J, Jeekel J, et al. Incidence, risk factors, and treatment of incisional hernia after kidney transplantation: An analysis of 1,564 consecutive patients. Surgery. 2016; 159: 1407–1411
Smith CT, Katz MG, Foley D, et al. Incidence and risk factors of incisional hernia formation following abdominal organ transplantation. Surg Endosc. 2015; 29: 398–404.
Kudiyirickal MG, Pappachan JM. Diabetes mellitus and oral health. Endocrine. 2015; 49(1): 27-34. doi: 10.1007/s12020-014-0496-3.
Nylund KM, Meurman JH, Heikkinen AM, et al. Oral health in patients with renal disease: a longitudinal study from predialysis to kidney transplantation. Clin Oral Investig. 2018; 22: 339–347.
Nylund K, Meurman JH, Heikkinen AM, et al. Oral health in predialysis patients with emphasis on periodontal disease. Quintessence Int. 2015; 46: 899–907.
Veisa G, Tasmoc A, Nistor I, et al. The impact of periodontal disease on physical and psychological domains in long-term hemodialysis patients: a cross-sectional study. Int Urol Nephrol. 2017; 49: 1261–1266.
Boissier, R., et al. Benefits and harms of benign prostatic obstruction treatments in renal transplanted patients. PROSPERO, 2019. CRD42019136477.
Boissier, R., et al. Effectiveness of interventions on nephrolithiasis in transplanted kidney. PROSPERO, 2019. CRD42019136474.
Grossman DC, Curry SJ, Owens DK, et al. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2018; 319: 1901–1913.
Wong G, Howard K, Webster AC, et al. Screening for renal cancer in recipients of kidney transplants. Nephrol Dial Transplant. 2011; 26: 1729–1739.
Smith RA, Andrews KS, Brooks D, et al. Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2019; 69: 184–210.
Siu AL. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2016; 164: 279–296.
Pop-Busui R, Braffett BH, Wessells H, Herman WH, Martin CL, Jacobson AM, Sarma AV. Diabetic Peripheral Neuropathy and Urological Complications in Type 1 Diabetes: Findings From the Epidemiology of Diabetes Interventions and Complications Study Diabetes Care. 2022 Jan 1;45(1):119-126.doi: 10.2337/dc21-1276.
Freeman R. Diabetic autonomic neuropathy. Handb Clin Neurol. 2014; 126: 63-79. doi: 10.1016/B978-0-444-53480-4.00006-0.
Sanders RD, Bottle A, Jameson SS, et al. Independent preoperative predictors of outcomes in orthopedic and vascular surgery: the influence of time interval between an acute coronary syndrome or stroke and the operation. Ann Surg. 2012; 255: 901–907.
Jorgensen ME, Torp-Pedersen C, Gislason GH, et al. Time elapsed after ischemic stroke and risk of adverse cardiovascular events and mortality following elective noncardiac surgery. JAMA. 2014; 312: 269–277.
LeFevre ML, Force USPST. Screening for asymptomatic carotid artery stenosis: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014; 161: 356–362.
Kakio Y, Uchida HA, Takeuchi H, et al. Diabetic nephropathy is associated with frailty in patients with chronic hemodialysis. Geriatr Gerontol Int. 2018;18(12):1597-1602.
Golingan H, Samuels SK, Camacho P, et al. Management of hyperparathyroidism in kidney transplantation candidates: a need for consensus. Endocr Pract. 2020; 26(3): 299-304. doi: 10.4158/EP-2019-0392. Epub 2019 Nov 4.
Keddis MT, El Ters M, Rodrigo E, et al. Enhanced posttransplant management of patients with diabetes improves patient outcomes. Kidney Int. 2014; 86: 610–618.
Rudolph EN, Dunn TB, Mauer D, et al. HLA-A, -B, -C, -DR, and -DQ Matching in Pancreas Transplantation: Effect on Graft Rejection and Survival. Am J Transplant. 2016; 16(8): 2401-12. doi: 10.1111/ajt.13734.
Berney T, Malaise J, Morel P, et al. Impact of HLA matching on the outcome of simultaneous pancreas-kidney transplantation. Euro-SPK Study Group. Nephrol Dial Transplant. 2005; 20 Suppl 2: ii48-53, ii62. doi: 10.1093/ndt/gfh1082.
De Clippel D, Baeten M, Torfs A, et al. Screening for HLA antibodies in plateletpheresis donors with a history of transfusion or pregnancy. Transfusion. 2014; 54: 3036–3042.
Bachelet T, Martinez C, Del Bello A, et al. Deleterious impact of donor- specific anti-HLA antibodies toward HLA-Cw and HLA-DP in kidney transplantation. Transplantation. 2016; 100: 159–166.
Filippone EJ, Farber JL. Humoral immune response and allograft function in kidney transplantation. Am J Kidney Dis. 2015; 66: 337–347.
Tait BD, Süsal C, Gebel HM, et al. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation. 2013; 95: 19–47.
Knoll GA, Nichol G. Dialysis, kidney transplantation, or pancreas transplantation for patients with diabetes mellitus and renal failure: a decision analysis of treatment options. J Am Soc Nephrol. 2003;14(2):500-515.
Mittel AM, Wagener G. Anesthesia for Kidney and Pancreas Transplantation. Anesthesiol Clin. 2017; 35(3): 439-452. doi: 10.1016/j.anclin.2017.04.005.
Allen UD, Preiksaitis JK, AST Infectious Diseases Community of Practice. Epstein-Barr virus and posttransplant lymphoproliferative disorder in solid organ transplantation. Am J Transplant. 2013; 13Suppl 4: 107–120.
Malinis M, Boucher HW. Screening of donor and candidate prior to solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019.
Levitsky J, Doucette K, AST Infectious Diseases Community of Practice. Viral hepatitis in solid organ transplantation. Am J Transplant. 2013; 13 Suppl 4: 147–168.
Burdick RA, Bragg-Gresham JL, Woods JD, et al. Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2003; 63: 2222–2229.
Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C Work Group. KDIGO 2018 Clinical Practice Guideline on the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney Int Suppl. 2018; 8: 91–165.
Kotton CN, Kumar D, Caliendo AM, et al. Updated international consensus guidelines on the management of cytomegalovirus in solid organ transplantation. Transplantation. 2013; 96: 333–360.
Humar A, et al. Venous thromboembolic complications after kidney and kidney-pancreas transplantation: a multivariate analysis. Transplantation. 1998; 65 (2): 229-234.
Muthusamy, Anand SR, Giangrande PLF, Friend PJ. Pancreas Allograft Thrombosis, Transplantation. 2010; 90 –(7): 705-707. doi: 10.1097/TP.0b013e3181eb2ea0.
MacCraith E, Davis NF, Browne C, Mohan P, Hickey D. Simultaneous pancreas and kidney transplantation: Incidence and risk factors for amputation after 10-year follow-up. Clin Transplant. 2017; 31(6). doi:10.1111/ctr.12976
Woeste G, Wullstein C, Pridöhl O, et al. Incidence of minor and major amputations after pancreas/kidney transplantation. Transpl Int. 2003; 16(2): 128-132.
Chen J, Mohler ER, 3rd, Garimella PS, et al. Ankle Brachial Index and Subsequent Cardiovascular Disease Risk in Patients With Chronic Kidney Disease. J Am Heart Assoc. 2016; 5: pii: e003339.
Wu SW, Lin CK, Hung TW, et al. Subclinical peripheral arterial disease in renal transplantation. Am J Med Sci. 2014; 347: 267–270.
Jenssen T, Hartmann A, Birkeland KI. Long-term diabetes complications after pancreas transplantation. Curr Opin Organ Transplant. 2017; 22(4): 382-388. doi:10.1097/MOT.0000000000000436
Sollinger HW, Odorico JS, Becker YT, et al. One thousand simultaneous pancreas-kidney transplants at a single center with 22-year follow-up. Ann Surg. 2009; 250(4): 618-629. doi:10.1097/SLA.0b013e3181b76d2b
Gill JS, Ma I, Landsberg D, et al. Cardiovascular events and investigation in patients who are awaiting cadaveric kidney transplantation. J Am Soc Nephrol. 2005; 16: 808–816.
Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014; 64: e77–137.
Hathaway DK, Abell T, Cardoso S, et al. Improvement in autonomic and gastric function following pancreas-kidney versus kidney-alone transplantation and the correlation with quality of life. Transplantation. 1994;57(6):816-822
Nawabi A, Serwar S, Klein J, et al. Nonoperative management of gastrointestinal bleeding after a simultaneous pancreas and kidney transplant. J Surg Case Rep. 2020; 10: rjaa433. doi: 10.1093/jscr/rjaa433.
Boissier R, Hevia V, Bruins H, et al. The risk of tumour recurrence of patients undergoing renal transplantation for end-stage renal disease after previous treatment for a urological cancer: a systematic review. Eur Urol, 2018; 73: 94-108.
Highshaw RA, Tunuguntla HS, Perez RV, Gandour-Edwards R, Evans CP. Initial report of bladder carcinoma following combined bladder-drained pancreas and kidney transplantation. Clin Transplant. 2002; 16(5): 383-6. doi: 10.1034/j.1399-0012.2002.02034.x. PMID: 12225437.
Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl): e326-50.
Task Force for Preoperative Cardiac Risk. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J, 2009; 30: 2769. https://academic.oup.com/eurheartj/article/30/22/2769/478458
Benahmed A, et al. Ticlopidine and clopidogrel, sometimes combined with aspirin, only minimally increase the surgical risk in renal transplantation: A case-control study. Nephrology Dialysis Transplantation. 2013; 29(2) doi:10.1093/ndt/gft385.
Saima A, Coleman Rotstein. Candida infections in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. AST Infectious Disease Community of Practice. Affiliations expand. PMID: 31155770 DOI: 10.1111/ctr.13623
Dupont D, Huguenin A, Tisserand E, et al. Donor Derived Candida stellimalicola in a Clinical Specimen: Preservation Fluid Contamination During Pancreas Procurement. Mycopathologia. 2018; 183(3): 573-577. doi: 10.1007/s11046-017-0171-3.
O’Malley, C.M., et al. A randomized, double-blind comparison of lactated Ringer’s solution and 0.9% NaCl during renal transplantation. Anesth Analg, 2005. 100: 1518.
Othman MM., et al. The impact of timing of maximal crystalloid hydration on early graft function during kidney transplantation. Anesth Analg. 2010; 110: 1440.
Fridell JA, Powelson JA, Sanders CE, Ciancio G, Burke GW 3rd, Stratta RJ. Preparation of the pancreas allograft for transplantation. Clin Transplant. 2011; 25(2): E103-12. doi: 10.1111/j.1399-0012.2011.01414.x.
Boggi U, Amorese G, Marchetti P. Surgical techniques for pancreas transplantation. Curr Opin Organ Transplant. 2010; 15(1): 102-11. doi: 10.1097/MOT.0b013e32833553de.
Schulz T, Flecken M, Schenker P. Pankreasorganentnahme durch externe Teams [Pancreas removal by external teams]. Chirurg. 2005; 76(6): 581-6; discussion 586-7. doi: 10.1007/s00104-004-0988-4. PMID: 15690215.
Baranski AG, Lam HD, Braat AE, Schaapherder AF. The dorsal pancreatic artery in pancreas procurement and transplantation: anatomical considerations and potential implications. Clin Transplant. 2016; 30(10): 1360-1364. doi: 10.1111/ctr.12814.
Bertelli E, Di Gregorio F, Bertelli L, Civeli L, Mosca S. The arterial blood supply of the pancreas: a review. III. The inferior pancreaticoduodenal artery. An anatomical review and a radiological study. Surg Radiol Anat. 1996; 18(2): 67-74. doi: 10.1007/BF01795221.
Boggi U, Amorese G, Marchetti P, Mosca F. Segmental live donor pancreas transplantation: review and critique of rationale, outcomes, and current recommendations. Clin Transplant. 2011; 25(1): 4-12. doi: 10.1111/j.1399-0012.2010.01381.x.
Lück R, Klempnauer J, Ehlerding G, Kühn K. Significance of portal venous drainage after whole-organ pancreas transplantation for endocrine graft function and prevention of diabetic nephropathy. Transplantation. 1990; 50(3): 394-8. doi: 10.1097/00007890-199009000-00008.
Bazerbachi F, Selzner M, Marquez MA, et al. Portal venous versus systemic venous drainage of pancreas grafts: impact on long-term results. Am J Transplant. 2012; 12(1): 226-32. doi: 10.1111/j.1600-6143.2011.03756.x.
Shokouh-Amiri MH, Gaber AO, Gaber LW, et al. Pancreas transplantation with portal venous drainage and enteric exocrine diversion: a new technique. Transplant Proc. 1992; 24(3): 776-7.
Ziaja J, Wullstein C, Woeste G, Bechstein WO. High duodeno-jejunal anastomosis as a safe method of enteric drainage in simultaneous pancreas and kidney transplantation. Ann Transplant. 2002; 7(3): 46-9.
Walter M, Jazra M, Kykalos S, et al. 125 Cases of duodenoduodenostomy in pancreas transplantation: a single-centre experience of an alternative enteric drainage. Transpl Int. 2014; 27(8): 805-15. doi: 10.1111/tri.12337.
Gruessner AC. 2011 update on pancreas transplantation: comprehensive trend analysis of 25,000 cases followed up over the course of twenty-four years at the International Pancreas Transplant Registry (IPTR). Rev Diabet Stud. 2011; 8(1): 6-16. doi: 10.1900/RDS.2011.8.6.
Troppmann C, Gruessner AC, Benedetti E, et al. Vascular graft thrombosis after pancreatic transplantation: univariate and multivariate operative and nonoperative risk factor analysis. J. Am. Coll. Surg. 1996; 182 (4): 285–316.
Adrogué HE, Matas AJ, McGlennon RC, et al. Do inherited hypercoagulable states play a role in thrombotic events affecting kidney/pancreas transplant recipients? Clin. Transplant. 2007; 21 (1): 32–37.
Ciancio G, Julian JF, Fernandez L, et al. Successful surgical salvage of pancreas allografts after complete venous thrombosis. Transplantation. 2000; 70(1): 126–131.
Maraschio MA, Kayler LK, Merion RM, et al. Successful surgical salvage of partial pancreatic allograft thrombosis. Transplant. Proc. 2003; 35(4): 1491–1493.
Stockland AH, Willingham DL, Paz-Fumagalli R. Pancreas transplant venous thrombosis: Role of endovascular interventions for graft salvage. Cardiovasc. Intervent. Radiol. 2009; 32(2): 279–283.
Miyagi S, Fujio A, Tokodai K, et al. Successful Case of Somatostatin Analog Stopping Gastrointestinal Bleeding, One of the Most Frequent Complications After Simultaneous Pancreas-kidney Transplantation: A Case Report. Transplant Proc. 2016; 48(3): 985-7. doi: 10.1016/j.transproceed.2015.10.072. PMID: 27234785.
Troppmann C. Complications after pancreas transplantation. Curr Opin Organ Transplant. 2010; 15(1): 112-8. doi: 10.1097/MOT.0b013e3283355349.
Büsing M, Hopt UT, Quacken M. Morphological studies of graft pancreatitis following pancreas transplantation. Br. J. Surg. 1993; 80(9): 1170–1173.
Hesse UJ, Meester D, Troisi R, et al. The use of low dose octreotide prophylaxis in pancreatic transplants with enteric drainage. Results of a prospective randomized single center trial. Clin Transplant. 2005; 19(3): 299-303. doi: 10.1111/j.1399-0012.2005.00208.x.
Nadalin S, Girotti P, Königsrainer A. Risk factors for and management of graft pancreatitis. Curr. Opin. Organ Transplant. 2013; 18(1): 89–96.
Marang-van de Mheen PJ, Hilling DE, Dirkes MC, et al. Surgical injuries of pancreatic allografts during procurement. Clin. Transplant. 2011; 25(5): 737–743.
Al-Adra D, McGilvray I, Goldaracena N, et al. Preserving the Pancreas Graft: Outcomes of Surgical Repair of Duodenal Leaks in Enterically Drained Pancreas Allografts. Transplant Direct. 2017; 3(7): e179. doi: 10.1097/TXD.0000000000000698.
Nath DS, Gruessner A, Kandaswamy R, et al. Late anastomotic leaks in pancreas transplant recipients - clinical characteristics and predisposing factors. Clin Transplant. 2005; 19(2): 220-4. doi: 10.1111/j.1399-0012.2005.00322.x.
Orsenigo E, Fiorina P, Dell"Antonio G, et al. Gastrointestinal bleeding from enterically drained transplanted pancreas. Transpl Int. 2005; 18(3): 296-302. doi: 10.1111/j.1432-2277.2004.00023.x.
Pieroni E, Napoli N, Lombardo C, et al. Duodenal graft complications requiring duodenectomy after pancreas and pancreas-kidney transplantation. Am J Transplant. 2018; 18(6): 1388-1396. doi: 10.1111/ajt.14613.
Kandaswamy R, Skeans MA, Gustafson SK, et al. K.B. OPTN/SRTR 2013 Annual data Report: pancreas. Am J Transpl. 2015; 15: 1–20.
Kandaswamy R., Stock PG., Gustafson SK. OPTN/SRTR 2015 Annual Data Report: Pancreas. Am. J. Transplant. 2017; 17: 117–173.
Caillard, S, et al. Advagraf ((R)), a once-daily prolonged release tacrolimus formulation, in kidney transplantation: literature review and guidelines from a panel of experts. Transpl Int. 2016; 29: 860.
McCormack PL. Extended-release tacrolimus: a review of its use in de novo kidney transplantation. Drugs. 2014; 74: 2053.
Molnar AO, et al. Generic immunosuppression in solid organ transplantation: systematic review and meta-analysis. BMJ. 2015; 350: h3163.
Amorese G, Lombardo C, Tudisco A, et al. Induction and immunosuppressive management of pancreas transplant recipients. Curr Pharm Des. 2020;26(28):3425-3439
Heilman RL, Mazur MJ, Reddy KS. Immunosuppression in simultaneous pancreas-kidney transplantation. Drugs. 2010; 70 (7): 793-804.
Jones-Hughes T, et al. Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model. Health Technol Assess. 2016; 20: 1.
Snanoudj R, et al. Immunological risks of minimization strategies. Transpl Int. 2015; 28: 901.
Budde K, et al. Enteric-coated mycophenolate sodium. Expert Opin Drug Saf. 2010; 9: 981
van Gelder T, et al. Mycophenolate revisited. Transpl Int. 2015; 28: 508.
Wagner M, et al. Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients. Cochrane Database Syst Rev. 2015; CD007746.
Hirsch HH, et al. European perspective on human polyomavirus infection, replication and disease in solid organ transplantation. Clin Microbiol Infect. 2014; 20 (Suppl 7): 74.
Cooper M, et al. Enteric-coated mycophenolate sodium immunosuppression in renal transplant patients: efficacy and dosing. Transplant Rev (Orlando). 2012; 26: 233.
Staatz CE, et al. Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update. Arch Toxicol. 2014; 88: 1351.
Haller MC, et al. Steroid avoidance or withdrawal for kidney transplant recipients. Cochrane Database Syst Rev. 2016: CD005632.
Diekmann F. Immunosuppressive minimization with mTOR inhibitors and belatacept. Transpl Int. 2015; 28: 921.
Ventura-Aguiar P, et al. Safety of mTOR inhibitors in adult solid organ transplantation. Expert Opin Drug Saf. 2016; 15: 303.
Berney Th, Andres A; Toso Ch, et al. mTOR Inhibition and Clinical Transplantation, Transplantation. 2018; 102 (2S): S30-S31. doi: 10.1097/TP.0000000000001700.
Liu Y, et al. Basiliximab or antithymocyte globulin for induction therapy in kidney transplantation: a meta-analysis. Transplant Proc. 2010; 42: 1667.
Sun ZJ, et al. Efficacy and Safety of Basiliximab Versus Daclizumab in Kidney Transplantation: A Meta-Analysis. Transplant Proc. 2015; 47: 2439.
Webster AC, et al. Interleukin 2 receptor antagonists for kidney transplant recipients. Cochrane Database Syst Rev. 2010; CD003897.
Bamoulid J, et al. Anti-thymocyte globulins in kidney transplantation: focus on current indications and long-term immunological side effects. Nephrol Dial Transplant. 2016.
Fernández-Burgos I, Montiel Casado MC, Pérez-Daga JA, et al. Induction therapy in simultaneous pancreas-kidney transplantation: thymoglobulin versus basiliximab. Transplant Proc. 2015; 47(1): 120-2. doi: 10.1016/j.transproceed.2014.12.003.
Malvezzi P, et al. Induction by anti-thymocyte globulins in kidney transplantation: a review of the literature and current usage. J Nephropathol. 2015; 4: 110.
Gruessner AC, Gruessner RWG. Pancreas transplantation of US and Non-US cases from 2005 to 2014 as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR). Rev. Diabet. Stud. 2016; 13(1): 35–58.
Gruessner A, Sutherland DE. Pancreas transplant results in the United Network for Organ Sharing (UNOS) United States of America (USA) Registry compared with non-USA data in the International Registry. Clin. Transpl. 1993; 47–68.
Gruessner AC, Sutherland DER. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of June 2004. Clin. Transplant. 2005; 19(4): 433–455.
Gruessner RWG, Gruessner AC. The current state of pancreas transplantation. Nat. Rev. Endocrinol. 2013; 9(9): 555–562.
Gruessner RWG, Gruessner AC. Pancreas transplant alone: A procedure coming of age. Diabetes Care. 2013; 36(8): 2440–2447.
Gruessner RWG. Sutherland DER. Transplantation of the Pancreas Springer Science & Business Media. 2004.
Bazerbachi F, Selzner M, Boehnert MU, et al. Thymoglobulin versus basiliximab induction therapy for simultaneous kidney-pancreas transplantation: impact on rejection, graft function, and long-term outcome. Transplantation. 2011; 92(9): 1039-43. doi: 10.1097/TP.0b013e3182313e4f.
Chow FY, Polkinghorne K, Saunder A, et al. Historical controlled trial of OKT3 versus basiliximab induction therapy in simultaneous pancreas-renal transplantation. Nephrology (Carlton). 2003; 8(4): 212-6. doi: 10.1046/j.1440-1797.2003.00158.x.
Zhang R, Florman S, Devidoss S, et al. The long-term survival of simultaneous pancreas and kidney transplant with basiliximab induction therapy. Clin Transplant. 2007; 21(5): 583-9. doi: 10.1111/j.1399-0012.2007.00692.x.
Федеральный закон от 21.11.2011 N 323-ФЗ (ред. от 31.07.2020) "Об основах охраны здоровья граждан в Российской Федерации".
Nicoletto BB, Fonseca NK, Manfro RC, Goncalves LF, Leitao CB, Souza GC. Effects of obesity on kidney transplantation outcomes: a systematic review and meta-analysis. Transplantation. 2014; 98: 167-76.
Bhaskaran K, Douglas I, Forbes H, et al. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet. 2014; 384: 755-65.
Evans S, Michael R, Wells H, et al. Drug interaction in a renal transplant patient: cyclosporin-Neoral and orlistat. American journal of kidney diseases: the official journal of the National Kidney Foundation 2003; 41: 493-6.
Heiwe S, Jacobson SH. Exercise Training in Adults With CKD: A Systematic Review and Meta-analysis. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2014;64:383-93.
Machnicki G, Pinsky B, Takemoto S, et al. Predictive ability of pretransplant comorbidities to predict long-term graft loss and death. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2009; 9: 494-505.
Parker R, Armstrong MJ, Corbett C, Day EJ, Neuberger JM. Alcohol and substance abuse in solid-organ transplant recipients. Transplantation. 2013; 96: 1015-24.
Pezeshki M, Taherian AA, Gharavy M, Ledger WL. Menstrual characteristics and pregnancy in women after renal transplantation. Int J Gynaecol Obstet. 2004; 85(2): 119–25.
Normand G, Brunner F, Badet L, et al. Pregnancy outcomes in simultaneous pancreas and kidney transplant recipients: a national French survey study. Transpl Int. 2017; 30(9): 893-902. doi: 10.1111/tri.12983.
Fang YE, Nayyar R, Diplock H. An audit of pregnancy outcomes in solid organ transplant recipients at a metropolitan hospital. Aust N Z J Obstet Gynaecol. 2019; 59(1): 102-104. doi: 10.1111/ajo.12815.
Stratta P, Canavese C, Giacchino F, et al. Pregnancy in kidney transplantation: satisfactory outcomes and harsh realities. J Nephrol. 2003; 16(6): 792-–806.
Bar J, Ben-Rafael Z, Pados A, et al. Prediction of pregnancy outcome in subgroups of women with renal disease. Clin Nephrol. 2000; 53(6): 437–44.
Hagay ZJ, Biran G, Ornoy A, Reece EA. Congenital cytomegalovirus infection: along-standing problem still seeking a solution. Am J Obstet Gynecol. 1996; 174(1 Pt 1): 241–5.
Kainz A, Harabacz I, Cowlrick IS, et al. Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus. Transplantation. 2000; 70(12): 1718–21.
Jain A, Venkataramanan R, Fung JJ, et al. Pregnancy after liver transplantation under tacrolimus. Transplantation. 1997; 64(4): 559–65.
Sifontis NM, Coscia LA, Costantinescu S, et al. Pregnancy outcomes in solid organ transplant recipients with exposure to micophenolate mofetil or sirolimus. Transplantation 2006; 82(12): 1698–702.
Davison JM, Milne JEC. Pregnancy and renal transplantation. Br J Urol. 1997; 80(Suppl 1): 29–32.
Sgro MD, Barozzino T, Mirghani HM, et al. Pregnancy outcome postrenal transplantation. Teratology. 2002; 65(1): 5–9.
Campbell S, Pilmore H, Gracey D, et al. KHA-CARI guideline: recipient assessment for transplantation. Nephrology (Carlton). 2013; 18: 455–462.
Fridell JA, Agarwal A, Powelson JA, Goggins WC, Milgrom M, Pescovitz MD, et al. Steroid withdrawal for pancreas after kidney transplantation in recipients on maintenance prednisone immunosuppression. Transplantation. 2006;82:389–92.
Boggi U, Vistoli F, Andres A at al. First World Consensus Conference on pancreas transplantation: Part II - recommendations. Am J Transplant. 2021 Sep;21 Suppl 3(Suppl 3):17-59. doi: 10.1111/ajt.16750. Epub 2021 Jul 29. PMID: 34245223; PMCID: PMC8518376.
Сonstantinescu S, Pai A, Coscia LA, Davison JM, Moritz MJ, Armenti VT. Breast-feeding after transplantation. Best Pract Res Clin Obstet Gynaecol. 2014 Nov;28(8):1163-73. doi: 10.1016/j.bpobgyn.2014.09.001. Epub 2014 Sep 16. PMID: 25271063.
Farney AC, Rogers J, Stratta RJ. Pancreas graft thrombosis: causes, prevention, diagnosis, and intervention. Curr Opin Organ Transplant. 2012 Feb;17(1):87-92. doi: 10.1097/MOT.0b013e32834ee717. PMID: 22186095.
Morales-Alvarez MC. Nephrotoxicity of Antimicrobials and Antibiotics. Adv Chronic Kidney Dis. 2020 Jan;27(1):31-37. doi: 10.1053/j.ackd.2019.08.001. PMID: 32146999.
Caretto A.,·Caldara R., Castiglioni M.T., Scavini M.,·Secchi A. Pregnancy after pancreas kidney transplantation // Journal of Nephrology (2020) 33:1009–1018https://doi.org/10.1007/s40620-020-00860-8.
Kim SJ, Smail N, Paraskevas S, et al. Kidney function before pancreas transplant alone predicts subsequent risk of end-stage renal disease. Transplantation. 2014;97(6):675-680
Gopal JP, Dor FJ, Crane JS, Herbert PE, Papalois VE, Muthusamy AS. Anticoagulation in simultaneous pancreas kidney transplantation - On what basis? World J Transplant. 2020 Jul 29;10(7):206-214. doi: 10.5500/wjt.v10.i7.206. PMID: 32844096; PMCID: PMC7416362.
The burden of coronary heart disease in simultaneous pancreas-kidney transplantation: coronary angiography as a diagnostic method for all? - a retrospective studyJoana Marques, Luísa Pereira, Ana Messias, Nuno Fonseca , Patrícia Cotovio 1, Aníbal Ferreira 1 4, Fernando Nolasco 1 4J Bras Nefrol 2022 Feb 28;S0101-28002022005019401. doi: 10.1590/2175-8239-JBN-2021-0156.
Silva, H.T., et al. Long-term follow-up of a phase III clinical trial comparing tacrolimus extendedrelease/MMF, tacrolimus/MMF, and cyclosporine/MMF in de novo kidney transplant recipients. Transplantation, 2014. 97: 636. https://pubmed.ncbi.nlm.nih.gov/24521771
Singh RP, Stratta RJ. Advances in immunosuppression for pancreas transplantation. Curr Opin Organ Transplant. 2008;13:79–84.
Matias P, Araujo MR, Romao JE, Abensur H, Noronha IL. Conversion to sirolimus in kidney-pancreas and pancreas transplantation. Transplant Proc. 2008;40:3601–5.
Cantarovich D, Vistoli F. Minimization protocols in pancreas transplantation. Transpl Int. 2009;22:61–8.
Boggi U. et al. Long-term (5 years) efficacy and safety of pancreas transplantation alone in type 1 diabetic patients //Transplantation. – 2012. – Т. 93. – №. 8. – С. 842-846.
Tena B., Vendrell M. Perioperative considerations for kidney and pancreas-kidney transplantation //Best Practice & Research Clinical Anaesthesiology. – 2020. – Т. 34. – №. 1. – С. 3-14.
Hickey D. P. et al. Urological complications of pancreatic transplantation //The Journal of urology. – 1997. – Т. 157. – №. 6. – С. 2042-2048
VELOSA J. A. et al. Pancreas transplantation at Mayo: I. Patient selection //Mayo Clinic Proceedings. – Elsevier, 1990. – Т. 65. – №. 4. – С. 475-482.
St. Michel D. et al. Assessing pancreas transplant candidate cardiac disease: preoperative protocol development at a rapidly growing transplant program //Methods and Protocols. – 2019. – Т. 2. – №. 4. – С. 82.
Gruessner R. W. G., Sutherland D. E. R. (ed.). Transplantation of the Pancreas. – Springer Science & Business Media, 2004.
Hartgrink H. H. et al. Effect of blood group and HLA matching on pancreas graft survival with the use of UW solution //Transplant international. – 1995. – Т. 8. – №. 5. – С. 366-373
Jiménez C. et al. Influence of dialysis modality on complications and patient and graft survival after pancreas-kidney transplantation //Transplantation proceedings. – Elsevier, 2008. – Т. 40. – №. 9. – С. 2999-3000.
Papalois B. E. et al. Long-term peritoneal dialysis before transplantation and intra-abdominal infection after simultaneous pancreas-kidney transplantations //Archives of Surgery. – 1996. – Т. 131. – №. 7. – С. 761-766.
Spiro M. D., Eilers H. Intraoperative care of the transplant patient //Anesthesiology Clinics. – 2013. – Т. 31. – №. 4. – С. 705-721.
Gilabert R. et al. Treatment and outcome of pancreatic venous graft thrombosis after kidney–pancreas transplantation //Journal of British Surgery. – 2002. – Т. 89. – №. 3. – С. 355-360.
Harbell J. W. et al. Splenic vein thrombosis following pancreas transplantation: identification of factors that support conservative management //American Journal of Transplantation. – 2017. – Т. 17. – №. 11. – С. 2955-2962.
Saudek F. et al. Efficacy and safety of tacrolimus compared with cyclosporin microemulsion in primary SPK transplantation: 3-year results of the Euro-SPK 001 trial //Nephrology Dialysis Transplantation. – 2005. – Т. 20. – №. suppl_2. – С. ii3-ii10.
Torabi, J.; Konicki, A.; Rocca, J.P.; Ajaimy, M.; Campbell, A.; Azzi, Y.; Pynadath, C.; Liriano-Ward, L.; Akalin, E.; Kinkhabwala, M.; et al. The use of LCP-Tacrolimus (Envarsus XR) in simultaneous pancreas and kidney (SPK) transplant recipients. Am. J. Surg. 2020, 219, 583–586.
Davis, S.; Gralla, J.; Klem, P.; Stites, E.; Wiseman, A.; Cooper, J.E. Tacrolimus Intrapatient Variability, Time in Therapeutic Range, and Risk of De Novo Donor–Specific Antibodies. Transplantation 2020, 104, 881–887
Coste G., Lemaitre F. The Role of Intra-Patient Variability of Tacrolimus Drug Concentrations in Solid Organ Transplantation: A Focus on Liver, Heart, Lung and Pancreas //Pharmaceutics. – 2022. – Т. 14. – №. 2. – С. 379.
Di Francesco F. et al. One year follow-up of steroid-free immunosuppression plus everolimus in isolated pancreas transplantation //Transplantation. – 2008. – Т. 86. – №. 8. – С. 1146-1147.
Oh J. M. et al. Comparison of azathioprine and mycophenolate mofetil for the prevention of acute rejection in recipients of pancreas transplantation //The Journal of Clinical Pharmacology. – 2001. – Т. 41. – №. 8. – С. 861-869.
Descourouez J. L. et al. Impact of intensive dosing of mycophenolate on pancreas allograft survival //Clinical Transplantation. – 2018. – Т. 32. – №. 7. – С. e13293.
Ojo A. O. et al. Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection //Transplantation. – 2000. – Т. 69. – №. 11. – С. 2405-2409.
Benedetti E. et al. Correlation between cystoscopic biopsy results and hypoamylasuria in bladder-drained pancreas transplants //Surgery. – 1995. – Т. 118. – №. 5. – С. 864-872.
Sollinger H. W. et al. Urological complications in 210 consecutive simultaneous pancreas-kidney transplants with bladder drainage //Annals of surgery. – 1993. – Т. 218. – №. 4. – С. 561.
Schenker P. et al. Long‐term results of pancreas transplantation in patients older than 50 years //Transplant international. – 2011. – Т. 24. – №. 2. – С. 136-142.
Burke G. W., Ciancio G., Sollinger H. W. Advances in pancreas transplantation //Transplantation. – 2004. – Т. 77. – №. 9. – С. S62-S67.
Demartines N., Schiesser M., Clavien P. A. An evidence‐based analysis of simultaneous pancreas‐kidney and pancreas transplantation alone //American Journal of Transplantation. – 2005. – Т. 5. – №. 11. – С. 2688-2697.

Для продолжения работы требуется Регистрация

Предыдущая страница

Следующая страница

Приложение А3. Справочные материалы, включая соответствие показаний к применению и противопоказаний, способов применения и доз лекарственных препаратов, инструкции по применению лекарственного препарата

Приложение Б. Алгоритмы действий врача

Приложение В. Информация для пациента

Данный блок поддерживает скрол*